Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Squalene synthase inhibitor-derived compound is potent inhibitor of protein farnesyltransferase

Sep. 18, 1998

Ilex Oncology and Symphar to develop novel anticancer drug

Sep. 18, 1998

Medarex signs new MAb development agreement

Sep. 18, 1998

SuperGen expands phase III trials of RFS-2000 in pancreatic cancer

Sep. 17, 1998

Inhibitors of telomerase focus of investigation at CRC Technology, U. Texas

Sep. 17, 1998

Novel treatment for breast cancer available for licensing

Sep. 16, 1998

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Positive clinical data from temozolomide trials presented at European oncology meeting

Sep. 16, 1998

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...